Martin Lackmann
Inventor
Stats
- 3 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 8 US Applications Filed
- 36 Total Citation Count
- Jul 5, 2018 Most Recent Filing
- Apr 23, 1993 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MEMORIAL SLOAN-KETTERING CANCER CENTER | 2
1 | 2005
2015 |
THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH | 1
| 2004
|
MONASH UNIVERSITY | 1
2 2 1 1 | 2004
2005 2008 2011 2015 |
THE HEART RESEARCH INSTITUTE LTD. | 1
| 1993
|
THE UNIVERSITY OF QUEENSLAND | 1
| 2004
|
HUMANIGEN, INC. | 2
| 2008
|
LUDWIG INSTITUTE FOR CANCER RESEARCH | 1
2 1 1 | 2004
2008 2011 2015 |
KALOBIOS PHARMACEUTICALS, INC. | 1
| 2011
|
Inventor Addresses
Address | Duration |
---|---|
Clayton, AU | Jun 14, 11 - Jun 14, 11 |
Newport, AU | Mar 24, 98 - Mar 24, 98 |
St Andrews Beach, AU | Jul 17, 18 - Jul 17, 18 |
St Andrews Beach, Victoria, AU | Jan 12, 17 - Jan 12, 17 |
St. Andrews Beach, AU | Nov 20, 08 - Nov 02, 21 |
Victoria, AU | Jun 29, 06 - Dec 25, 08 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
C07K: | PEPTIDES | 6 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11160873 | 2021 | Anti-metalloprotease antibody for diagnosis and treatment of cancers | 0 |
2019/0105,405 | 2019 | ANTI-METALLOPROTEASE ANTIBODY FOR DIAGNOSIS AND TREATMENT OF CANCERS | 0 |
10023653 | 2018 | Anti-metalloprotease antibody for diagnosis and treatment of cancers | 0 |
2017/0335,001 | 2017 | Detection of EphA3 as a Marker of the Presence of a Solid Tumor | 0 |
2017/0008,976 | 2017 | ANTI-METALLOPROTEASE ANTIBODY FOR DIAGNOSIS AND TREATMENT OF CANCERS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.